29
Views
1
CrossRef citations to date
0
Altmetric
GYNECOLOGY

Timing of heparin prophylaxis and bleeding complications in hysterectomy a nationwide prospective cohort study of 9,949 Danish women

, , , , &
Pages 1039-1047 | Received 18 Jul 2008, Published online: 03 Aug 2009

References

  • Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004; 126: 338–400
  • Raskob GE, Hirsh J. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest. 2003; 124: 379–85
  • Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, et al. Low-molecular-weight heparin prophylaxis using Dalteparin in close proximity to surgery vs. Warfarin in hip arthroplasty patients: a double-blind, randomised comparison: North American Fragmin Trial Investigators. Arch Intern Med. 2000; 160: 2199–207
  • Hull RD, Brant RF, Pineo GF, Stein PD, Raskob GE, Valentine KA. Preoperative vs. postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med. 1999; 156: 137–41
  • Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, et al. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty. Arch Intern Med. 2001; 161: 1952–60
  • Strebel N, Prins M, Agnelli G, Büller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?. Arch Intern Med. 2002; 162: 1451–6
  • Harris WJ. Complications of hysterectomy. Clin Obstet Gynecol. 1997; 40: 928–38
  • Johnson N, Barlow D, Lethaby A, Tavender E, Curr E, Garry R. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD003677. DOI: 10.1002/14651858.CD003677.pub3.
  • Moller C, Kehlet H, Utzon J, Ottesen B. Hysterectomy in Denmark. An analysis of postoperative hospitalisation, morbidity and readmission. Dan Med Bull. 2002; 49: 353–7
  • Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999; 46: 263–8
  • Lethaby A, Ivanova V, Johnson NP. Total versus subtotal hysterectomy for benign gynaecological conditions. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD004993. DOI: 10.1002/14651858.CD004993.pub2.
  • Mueller RL. First-generation agents: aspirin, heparin and coumarins. Best Pract Res Clin Haematol. 2004; 17: 23–53
  • Slappendel R, Weber EW, Benraad B, Dirksen R, Bugter ML. Does ibuprofen increase perioperative blood loss during hip arthroplasty?. Eur J Anaesthesiol. 2002; 19: 829–31
  • Hegi TR, Bombeli T, Seifert B, Baumann PC, Haller U, Zalunardo MP. Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac. Br J Anaesth. 2004; 92: 523–31
  • Zemmel MH. The role of COX-2 inhibitors in the perioperative setting: efficacy and safety – a systematic review. Am Ass Nur Anesth J. 2006; 74: 49–60
  • Hosmer DW, Lemeshow S. Applied logistic regression. John Wiley & Sons, Inc, USA 2000
  • Gimbel H, Zobbe V, Andersen BM, Filtenborg T, Gluud C, Tabor A. Randomised controlled trial of total compared with subtotal hysterectomy with one-year follow up results. BJOG. 2003; 110: 1088–98
  • Beckmann M, Neppe C. Morbidity associated with vaginal hysterectomies in Queensland public teaching hospitals. Aust NZ J Obstet Gynaecol. 2007; 47: 70–5
  • Dicker R, Greenspan JR, Strauss LT, Cowart MR, Scally MJ, Peterson HB, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol. 1982; 144: 841–8
  • Thakar R, Ayers S, Clarkson P, Stanton S, Manyonda I. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med. 2002; 347: 1318–25
  • Davis JD. Prevention, diagnosis, and treatment of venous thromboembolic complications of gynaecologic surgery. Am J Obstet Gynecol. 2001; 184: 759–75
  • Mäkinen J, Johansson J, Tomás C, Tomás E, Heinonen PK, Laatikainen T, et al. Morbidity of 10 110 hysterectomies by type of approach. Hum Reprod. 2001; 16: 1473–8
  • Møller C, Kehlet H, Friland SG, Schouenborg LO, Lund C, Ottesen B. Fast track hysterectomy. Eur J Obstet Gynaecol Reprod Biol. 2001; 98: 18–22
  • Palmer AJ, Schramm W, Kirchhof B, Bergmann R. Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomised clinical trials. Haemostasis. 1997; 27: 65–74
  • Cook G, Depares J, Singh M, McElduff P. Readmission after hysterectomy and prophylactic low molecular weight heparin: retrospective case-control study. BMJ. 2006; 332: 819–20
  • Sorensen HT, Lash TL, Rothman KJ. Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology. 2006; 44: 1075–82
  • Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002; 359: 248–52

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.